Alkermes Shares Outstanding 2006-2018 | ALKS

Alkermes shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Alkermes shares outstanding for the quarter ending September 30, 2018 were 0.155B, a 1.07% increase year-over-year.
  • Alkermes 2017 shares outstanding were 0.153B, a 1.27% increase from 2016.
  • Alkermes 2016 shares outstanding were 0.151B, a 1.53% increase from 2015.
  • Alkermes 2015 shares outstanding were 0.149B, a 2.71% increase from 2014.
Alkermes Annual Shares Outstanding
(Millions of Shares)
2017 153
2016 151
2015 149
2014 145
2013 145
2013 137
2012 115
2011 96
2010 95
2009 96
2008 103
2007 103
2006 97
2005 90
Alkermes Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 155
Q2 2018 155
Q1 2018 154
Q4 2017 153
Q3 2017 154
Q2 2017 153
Q1 2017 153
Q4 2016 151
Q3 2016 152
Q2 2016 151
Q1 2016 151
Q4 2015 149
Q3 2015 150
Q2 2015 149
Q1 2015 148
Q4 2014 145
Q3 2014 146
Q2 2014 154
Q1 2014 143
Q4 2013 146
Q3 2013 136
Q2 2013 143
Q1 2013 140
Q4 2012 137
Q3 2012 131
Q2 2012 135
Q1 2012 130
Q4 2011 130
Q3 2011 102
Q2 2011 97
Q1 2011 0
Q4 2010 96
Q3 2010 96
Q2 2010 95
Q1 2010 0
Q4 2009 95
Q3 2009 95
Q2 2009 95
Q1 2009 0
Q4 2008 96
Q3 2008 97
Q2 2008 97
Q1 2008 0
Q4 2007 104
Q3 2007 104
Q2 2007 104
Q1 2007 0
Q4 2006 105
Q3 2006 106
Q2 2006 94
Q1 2006 0
Q4 2005 97
Q3 2005 97
Q2 2005 90
Q1 2005 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.193B $0.903B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.175B 14.15
Gilead Sciences (GILD) United States $87.410B 10.52
Biogen (BIIB) United States $64.370B 13.03
Celgene (CELG) United States $46.675B 9.06
Illumina (ILMN) United States $44.259B 51.56
Vertex Pharmaceuticals (VRTX) United States $40.828B 71.32
Regeneron Pharmaceuticals (REGN) United States $36.498B 18.49
Alexion Pharmaceuticals (ALXN) United States $26.062B 17.83
BioMarin Pharmaceutical (BMRN) United States $16.287B 0.00
Incyte (INCY) United States $13.532B 374.06
Seattle Genetics (SGEN) United States $8.999B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.107B 51.83
Exact Sciences (EXAS) United States $7.955B 0.00
Sarepta Therapeutics (SRPT) United States $7.830B 0.00
QIAGEN (QGEN) Netherlands $7.739B 24.75
Alnylam Pharmaceuticals (ALNY) United States $7.341B 0.00
BeiGene (BGNE) Cayman Islands $6.765B 0.00
Bluebird Bio (BLUE) United States $6.364B 0.00
Bio-Techne Corp (TECH) United States $5.904B 39.88
Exelixis (EXEL) United States $5.283B 14.98
Galapagos (GLPG) Belgium $5.072B 0.00
Amarin (AMRN) Ireland $5.066B 0.00
Immunomedics (IMMU) United States $3.555B 0.00
Emergent Biosolutions (EBS) United States $3.553B 29.93
Horizon Pharma Public (HZNP) Ireland $3.448B 14.19
MorphoSys AG Unsponsored ADR (MOR) Germany $3.360B 0.00
Array BioPharma (ARRY) United States $3.249B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.166B 0.00
Ligand Pharmaceuticals (LGND) United States $3.164B 24.20
Guardant Health (GH) United States $2.979B 0.00
Allogene Therapeutics (ALLO) United States $2.943B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.743B 0.00
Repligen (RGEN) United States $2.697B 84.25
Genomic Health (GHDX) United States $2.628B 88.72
Akcea Therapeutics (AKCA) United States $2.619B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.579B 0.00
China Biologic Products (CBPO) China $2.502B 17.81
Ascendis Pharma (ASND) Denmark $2.406B 0.00
Myriad Genetics (MYGN) United States $2.370B 23.48
Acceleron Pharma (XLRN) United States $2.300B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.281B 0.00
Allakos (ALLK) United States $2.280B 0.00
Blueprint Medicines (BPMC) United States $2.277B 0.00
Halozyme Therapeutics (HALO) United States $2.258B 50.39
MyoKardia (MYOK) United States $2.231B 0.00
REGENXBIO (RGNX) United States $2.181B 29.25
Arena Pharmaceuticals (ARNA) United States $1.942B 0.00
Amicus Therapeutics (FOLD) United States $1.895B 0.00
AnaptysBio (ANAB) United States $1.847B 0.00
Reata Pharmaceuticals (RETA) United States $1.822B 0.00
Denali Therapeutics (DNLI) United States $1.760B 0.00
Global Blood Therapeutics (GBT) United States $1.724B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.699B 0.00
Innoviva (INVA) United States $1.660B 9.39
Atara Biotherapeutics (ATRA) United States $1.622B 0.00
Cambrex (CBM) United States $1.603B 11.97
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.598B 0.00
Medicines (MDCO) United States $1.510B 0.00
Rubius Therapeutics (RUBY) United States $1.504B 0.00
Aimmune Therapeutics (AIMT) United States $1.479B 0.00
Spark Therapeutics (ONCE) United States $1.464B 0.00
NeoGenomics (NEO) United States $1.451B 120.00
G1 THERAPEUTICS (GTHX) United States $1.419B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.399B 0.00
Mirati Therapeutics (MRTX) United States $1.343B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.307B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Insmed (INSM) United States $1.287B 0.00
Myovant Sciences (MYOV) United Kingdom $1.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.245B 98.88
Editas Medicine (EDIT) United States $1.222B 0.00
WAVE Life Sciences (WVE) Singapore $1.201B 0.00
Solid Biosciences (SLDB) United States $1.170B 0.00
IMMURON LTD (IMRN) Australia $1.141B 0.00
Lion Biotechnologies (IOVA) United States $1.084B 0.00
Sangamo Therapeutics (SGMO) United States $1.077B 0.00
Retrophin (RTRX) United States $1.033B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.998B 0.00
UniQure (QURE) Netherlands $0.979B 0.00
Audentes Therapeutics (BOLD) United States $0.977B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.953B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.937B 0.00
Clovis Oncology (CLVS) United States $0.916B 0.00
Acorda Therapeutics (ACOR) United States $0.883B 11.18
Puma Biotechnology (PBYI) United States $0.882B 0.00
DBV Technologies (DBVT) France $0.881B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.875B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.869B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.847B 0.00
Cellectis (CLLS) France $0.841B 0.00
Intra-Cellular Therapies (ITCI) United States $0.839B 0.00
Viking Therapeutics (VKTX) United States $0.837B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.836B 0.00
Apellis Pharmaceuticals (APLS) United States $0.809B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.808B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.801B 0.00
Fate Therapeutics (FATE) United States $0.794B 0.00
Coherus BioSciences (CHRS) United States $0.790B 0.00
Athenex (ATNX) United States $0.779B 0.00
Revance Therapeutics (RVNC) United States $0.752B 0.00
Aptinyx (APTX) United States $0.751B 0.00
Heska (HSKA) United States $0.746B 61.03
ProQR Therapeutics (PRQR) Netherlands $0.741B 0.00
Dynavax Technologies (DVAX) United States $0.724B 0.00
Vericel (VCEL) United States $0.722B 0.00
Intellia Therapeutics (NTLA) United States $0.711B 0.00
Cara Therapeutics (CARA) United States $0.697B 0.00
AC Immune SA (ACIU) Switzerland $0.655B 0.00
Novavax (NVAX) United States $0.643B 0.00
UROGEN PHARMA (URGN) Israel $0.641B 0.00
TWIST BIOSCIENC (TWST) United States $0.640B 0.00
Gritstone Oncology (GRTS) United States $0.637B 0.00
ANI Pharmaceuticals (ANIP) United States $0.634B 12.12
AMAG Pharmaceuticals (AMAG) United States $0.622B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.617B 0.00
InflaRx (IFRX) Germany $0.609B 0.00
Principia Biopharma (PRNB) United States $0.592B 0.00
Epizyme (EPZM) United States $0.572B 0.00
CytomX Therapeutics (CTMX) United States $0.571B 0.00
Arvinas (ARVN) United States $0.571B 0.00
Senesco Technologies (ELOX) United States $0.564B 0.00
Scholar Rock Holding (SRRK) United States $0.557B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.557B 0.00
AVROBIO (AVRO) United States $0.528B 0.00
Eidos Therapeutics (EIDX) United States $0.522B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.517B 0.00
BeyondSpring (BYSI) United States $0.514B 0.00
UNITY Biotechnology (UBX) $0.511B 0.00
Arcus Biosciences (RCUS) United States $0.490B 0.00
Anika Therapeutics (ANIK) United States $0.482B 19.97
Inovio Pharmaceuticals (INO) United States $0.480B 0.00
Kezar Life Sciences (KZR) United States $0.467B 0.00
Prothena (PRTA) Ireland $0.462B 0.00
RA PHARMCTL INC (RARX) United States $0.462B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.459B 0.00
Kura Oncology (KURA) United States $0.454B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.441B 0.00
Mesoblast (MESO) Australia $0.436B 0.00
ObsEva SA (OBSV) Switzerland $0.435B 0.00
Kindred Biosciences (KIN) United States $0.429B 0.00
Sinovac Biotech (SVA) China $0.427B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.425B 0.00
PDL BioPharma (PDLI) United States $0.423B 6.90
Replimune (REPL) United States $0.421B 0.00
Sorrento Therapeutics (SRNE) United States $0.410B 67.00
Five Prime Therapeutics (FPRX) United States $0.403B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.402B 0.00
Cytokineticsorporated (CYTK) United States $0.390B 0.00
MediciNova (MNOV) United States $0.389B 0.00
Zealand Pharma (ZEAL) Denmark $0.385B 4.24
Zymeworks (ZYME) Canada $0.384B 0.00
Verastem (VSTM) United States $0.372B 0.00
Abeona Therapeutics (ABEO) United States $0.367B 0.00
Osiris Therapeutics (OSIR) United States $0.365B 0.00
MeiraGTx Holdings (MGTX) United States $0.355B 0.00
ResTORbio (TORC) United States $0.343B 0.00
Merus (MRUS) Netherlands $0.341B 0.00
Stemline Therapeutics (STML) United States $0.335B 0.00
Seres Therapeutics (MCRB) United States $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Liquidia Technologies (LQDA) United States $0.325B 0.00
LogicBio Therapeutics (LOGC) United States $0.310B 0.00
Krystal Biotech (KRYS) United States $0.297B 0.00
Evelo Biosciences (EVLO) United States $0.293B 0.00
Kadmon Holdings (KDMN) United States $0.288B 0.00
Albireo Pharma (ALBO) United States $0.287B 0.00
Kodiak Sciences (KOD) United States $0.286B 0.00
Geron (GERN) United States $0.283B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.272B 0.00
MannKind (MNKD) United States $0.270B 0.00
Athersys (ATHX) United States $0.266B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.263B 0.00
Agenus (AGEN) United States $0.259B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.258B 0.00
BioDelivery Sciences (BDSI) United States $0.257B 0.00
Syros Pharmaceuticals (SYRS) United States $0.255B 0.00
Magenta Therapeutics (MGTA) United States $0.253B 0.00
Equillium (EQ) United States $0.252B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.251B 0.00
Arbutus Biopharma (ABUS) Canada $0.247B 0.00
Aduro Biotech (ADRO) United States $0.242B 0.00
Celyad SA (CYAD) Belgium $0.242B 0.00
Urovant Sciences (UROV) United States $0.241B 0.00
Celcuity (CELC) United States $0.239B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.238B 0.00
Strongbridge Biopharma (SBBP) United States $0.238B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.234B 0.00
TOCAGEN INC (TOCA) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
Sutro Biopharma (STRO) United States $0.227B 0.00
Unum Therapeutics (UMRX) United States $0.223B 0.00
Synlogic (SYBX) United States $0.222B 0.00
Axovant Sciences (AXON) United Kingdom $0.219B 0.00
BioTime (BTX) United States $0.215B 0.00
Proteostasis Therapeutics (PTI) United States $0.209B 0.00
Kamada (KMDA) Israel $0.207B 19.04
Kala Pharmaceuticals (KALA) United States $0.206B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.206B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.205B 0.00
Idera Pharmaceuticals (IDRA) United States $0.198B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.191B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.187B 0.00
ChromaDex (CDXC) United States $0.187B 0.00
Intec Pharma (NTEC) Israel $0.184B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.180B 0.00
Protagonist Therapeutics (PTGX) United States $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.177B 0.00
Allena Pharmaceuticals (ALNA) United States $0.167B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.165B 0.00
NantKwest (NK) United States $0.165B 0.00
Compugen (CGEN) Israel $0.161B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.161B 0.00
PSivida (EYPT) United States $0.154B 0.00
XBiotech (XBIT) United States $0.150B 0.00
Constellation Pharmaceuticals (CNST) United States $0.149B 0.00
Menlo Therapeutics (MNLO) United States $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.148B 0.00
Cerecor (CERC) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Spero Therapeutics (SPRO) United States $0.141B 0.00
Palatin Technologies (PTN) United States $0.140B 17.25
Pfenex (PFNX) United States $0.138B 0.00
Selecta Biosciences (SELB) United States $0.133B 0.00
Eleven Biotherapeutics (SESN) United States $0.132B 0.00
Cohbar (CWBR) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Applied Genetic Technologies (AGTC) United States $0.122B 0.00
CorMedix Inc (CRMD) United States $0.121B 0.00
Mersana Therapeutics (MRSN) United States $0.119B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.118B 0.00
XOMA (XOMA) United States $0.118B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.117B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.117B 0.00
Organovo Holdings (ONVO) United States $0.110B 0.00
Mustang Bio (MBIO) United States $0.107B 0.00
VBI Vaccines (VBIV) United States $0.106B 0.00
Motif Bio Plc (MTFB) United States $0.105B 0.00
Cue Biopharma (CUE) United States $0.104B 0.00
Signal Genetics (MGEN) United States $0.104B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.100B 0.00
OVID THERAPEUTC (OVID) United States $0.099B 0.00
Cidara Therapeutics (CDTX) United States $0.099B 0.00
Anavex Life Sciences (AVXL) United States $0.098B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
Provention Bio (PRVB) United States $0.093B 0.00
Axsome Therapeutics (AXSM) United States $0.092B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Cocrystal Pharma (COCP) United States $0.087B 96.67
Orgenesis (ORGS) United States $0.086B 0.00
Aptose Biosciences (APTO) Canada $0.082B 0.00
Cel-Sci (CVM) United States $0.080B 0.00
Fortress Biotech (FBIO) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
BioXcel Therapeutics (BTAI) United States $0.079B 0.00
ScPharmaceuticals (SCPH) United States $0.077B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Ophthotech (OPHT) United States $0.076B 0.00
VolitionRX (VNRX) Singapore $0.076B 0.00
ITUS (ANIX) United States $0.072B 0.00
Monster Digital (INNT) United States $0.072B 0.00
Asterias Biotherapeutics (AST) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.069B 0.00
Versartis (ARAV) United States $0.066B 5.81
Brainstorm Cell Therapeutics (BCLI) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Alcobra (ARCT) United States $0.065B 0.00
Evogene (EVGN) Israel $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
PHASEBIO PHARMA (PHAS) United States $0.061B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Clearside Biomedical (CLSD) United States $0.058B 0.00
Aptevo Therapeutics (APVO) United States $0.057B 0.00
Sophiris Bio (SPHS) United States $0.057B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.055B 0.00
Bellerophon Therapeutics (BLPH) United States $0.053B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.053B 8.56
Oncobiologics (ONS) United States $0.053B 0.00
Leap Therapeutics (LPTX) United States $0.052B 0.00
Trevena (TRVN) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.050B 9.44
OncoSec Medical (ONCS) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.041B 0.00
Oncolytics Biotech (ONCY) Canada $0.041B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
TRACON Pharmaceuticals (TCON) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Celsion (CLSN) United States $0.034B 0.00
GTx (GTXI) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
VIVUS (VVUS) United States $0.032B 0.00
BioPharmX (BPMX) United States $0.031B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Histogenics (HSGX) United States $0.028B 0.00
Therapix Biosciences (TRPX) Israel $0.027B 10.13
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Advaxis (ADXS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
CytRx (CYTR) United States $0.020B 0.00
GENPREX INC (GNPX) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Arsanis (ASNS) United States $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
IBio (IBIO) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Oragenics (OGEN) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.005B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00